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ABSTRACT A stopped-flow spectroscopic technique was used
to study the kinetics of ion transport by reconstituted membrane
preparations containing purified acetylcholine receptor. Influx of
thallium (I) into membrane vesicles was monitored as a decrease,
due to quenching by the thallous ion, in the fluorescence of an en-
trapped fluorophore. In a reproducible manner, the reconstituted
receptor responded to cholinergic agonists by mediating rapid ion
transport in the millisecond time range. The effect of agonists was
blocked by receptor desensitization and by histrionicotoxin and
was absent in membrane vesicles lacking receptor. Analysis of the
fast kinetics of cation transport produced by saturating concentra-
tions of agonists yielded an estimated rate of transport through a
single reconstituted receptor channel. Comparison of this rate
with those reported for in vivo preparations and for purified mem-
branes shows that the reconstituted protein closely resembles the
physiologically active receptor.
The acetylcholine (AcCho) receptor (AcChoR) from Torpedo
californica electroplax is a pentamer composed of two identical
and three related and homologous polypeptides (1) and having
Mr 255,000 based on the stoichiometry of the subunits (1, 2).
Membrane preparations containing no protein components
other than the receptor complex have been shown to bind ago-
nists (3, 4), antagonists (5, 6), and neurotoxins (7-9), as well as a
local anesthetic analogue (10) and histrionicotoxin (HTX) (10,
11). In addition, such preparations respond to cholinergic ago-
nists by mediating cation translocation into or out ofthe interior
of the membrane vesicles (10, 12). Studies of this cation trans-
location using both slow (13) and fast (14) kinetic methods have
led to the conclusion that this single molecular complex is the
only protein component necessary for full function in terms of
cation transport. Preliminary reports of cation transport by re-
constituted preparations derived from purified AcChoR (15-18)
have shown qualitatively that the AcChoR complex is capable
of conducting cation transport. However, these studies have not
allowed the quantitation of cation translocation necessary for
determination of whether the reconstituted preparations retain
the full physiological properties of the receptor in vivo.
Recently, we developed a spectroscopic method that allows
study of ion translocation on the time scale achievable by
stopped-flow spectroscopy; i.e., a few milliseconds (14). In the
work reported here, we used this method to resolve the kinetics
of ion transport across reconstituted AcChoR-containing mem-
brane vesicles. Quantitative analysis ofthe fast ion-flux kinetics
yielded an AcChoR-mediated transport rate that is comparable
with that reported for in vivo preparations.
MATERIALS AND METHODS
Preparation of Purified AcChoR-Containing Membranes.
Highly purified AcChoR-containing membranes were obtained
as described (19, 20). These preparations have been shown to
contain only the four polypeptides ofthe AcChoR on the basis of
criteria such as NaDodSO4/polyacrylamide gel analysis (19, 20)
and NH2-terminal amino acid sequence analyses (1).
Solubilization and Reconstitution of AcChoR. The AcChoR
protein was extracted from the purified membranes and recon-
stituted as described (15, 20) with the following modifications.
Purified membranes were solubilized in Na buffer (10 mM Na
Hepes, pH 7.4/200 mM NaNO3 containing 2% Na cholate and
sonicated asolectin at an asolectin/protein ratio of 2:1. After
removal of nonsolubilized material by centrifugation at
140,000 x g for 1 hr, sonicated asolectin was added to a final
asolectin/protein ratio of 10:1. The protein/lipid mixture was
stirred for 15 min and centrifuged at 140,000 X g for 30 min.
Detergent was removed by dialysis against 1000 vol of Na buffer
at room temperature for 20 hr.
Loading of Reconstituted AcChoR-Containing Vesicles with
Fluorophore. The fluorophore 8-aminonaphthalene-1,3,6-tri-
sulfonate (ANTS) was purchased from Chemical Service, West
Chester, PA. It was loaded into reconstituted vesicles by the
freeze-thaw procedure (14), except for the following changes:
0.5 vol of 25 mM ANTS in 10 mM Na Hepes, pH 7.4/125 mM
NaNO3 was mixed with 1 vol of reconstituted membrane ves-
icles at room temperature. The mixture was frozen and kept at
-90°C for 30 min and then allowed to thaw gradually at room
temperature, usually for 1.5-2 hr. Removal of external ANTS
was achieved by passing the thawed mixture through a 1.7 x
24 cm Sephadex G-25 column. Reconstituted AcChoR-contain-
ing vesicles loaded with ANTS (reconstituted ANTS vesicles)
were collected in the void volume and used for cation flux stud-
ies without further dilution.
Quantitation of a-Bungarotoxin Sites and of Phospholipids
in Reconstituted Preparations. Reconstituted ANTS vesicles
were assayed for '25I-labeled a-bungarotoxin (a-BuTx) binding
sites (0.22-0.31 uM) according to published procedures (21).
The phospholipid content of the same vesicle preparation (3
mM) was determined by a modified version (22) of the total
phosphorus assay of Fiske and SubbaRow, except that a combi-
nation of 1.25 M H2SO4 and 10% HNO3 was used in place of
HC104 during lipid digestion.
Stopped-Flow Measurements of Thallium Transport into
Reconstituted AcChoR Vesicles. T1+ transport in reconstituted
preparations was measured in a stopped-flow instrument as
described (14). Tl+ flux was initiated by rapid mixing at 250C
of a reconstituted ANTS-vesicle suspension and an equal vol-
ume of 28 mM TINO3 in 10 mM Na Hepes, pH 7.4/172 mM
NaNO3 containing a nicotinic agonist and, in some cases, HTX.
Fluorescence emission was monitored and analyzed as reported
(14). HTX was a generous gift of R. Cherpeck and D. E. Evans.
Abbreviations: AcCho, acetylcholine; AcChoR, acetylcholine receptor;
ANTS, 8-amino-naphthalene-1,3,6-trisulfonate; a-BuTx, a-bungaro-
toxin; CarbCho, carbamoylcholine; HTX, histrionicotoxin.
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RESULTS
Kinetics of Thallium Influx Across Reconstituted Mem-
brane Vesicles Containing Purified AcChoR. Transport of TV+
into vesicles was studied by measuring the decrease in ANTS
fluorescence due to quenching by Tl (Fig. 1). When reconsti-
tuted ANTS vesicles were rapidly mixed with TV+ in a stopped-
flow instrument, a fluorescence decay with a half-time of -0.9
sec was observed (data not shown). This decay presumably rep-
resents leakage of Tl through the membrane and into the in-
terior of the vesicles. Addition of 1 mM carbamoylcholine
(CarbCho) in the TlNOJHepes buffer resulted in a marked
acceleration of this fluorescence decay (Fig. 2 A and B). This
rapid fluorescence decay had a half-time of about 5 msec. At
significantly lower concentrations, AcCho had a similar effect
(Fig. 3B) on the fluorescence decay. Thus, activation of the ion
channel of the AcChoR greatly enhanced the rate of influx of
TV+. These results show that the reconstituted membranes con-
taining purified AcChoR retain the capability to induce cation
permeation in response to nicotinic agonists on a physiological
time scale.
400-600A
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FIG. 1. Schematic diagram depicting fluorophore entrapped in re-
constituted AcChoR vesicles. (Upper) On addition ofa cholinergic ago-
nist and Tl+ to the vesicle exterior, the receptor channel opens (Lower)
to allow entry of T1+ (all cations present may respond via a simple bi-
directional equilibration). Fluorescence emission by the entrapped
fluorophore is instantaneously quenched by T1+.
Several observations suggest that the rapid enhancement of
TlV influx produced by CarbCho was a specific effect. TlV leak-
age into liposomes lacking AcChoR had a half-time of about 0.5
sec, and this was not altered by addition of agonist (see Fig. 2
G and H). The data in Fig. 2 C and D show that the CarbCho-
activated acceleration of fluorescence decay was completely
abolished by 10 uM HTX, a toxin reported to possibly interact
with AcChoR-associated ion channels (23, 24). In addition, de-
sensitization resulting from preincubation of reconstituted
AcChoR-containing vesicles with 100 uM CarbCho inhibited
the rapid fluorescence decay (Fig. 2 E and F) produced by 1
mM CarbCho. These results show that the reconstituted prep-
arations manifest the pharmacological properties of the AcChoR
on the physiologically significant time scale.
Rate of Ion Transport Through a Single Reconstituted
AcChoR Molecule. An important question concerning the re-
constituted membranes is whether the receptor has preserved
its full functional integrity with respect to its capability to me-
diate the very high rate of agonist-activated ion transport re-
corded in vivo (25-27). Accordingly, the rate of ion transport
per vesicle at saturating concentrations of CarbCho was esti-
mated by dividing the observed full flux rate by the average
number of receptor molecules per vesicle to obtain the number
of ions transported through a reconstituted receptor channel
per second.
Flux experiments carried out at higher concentrations of
CarbCho or AcCho gave fluorescence traces with higher decay
rates. At concentrations of CarbCho or AcCho > 1 or 40 uM,
respectively, the initial phase of the cation transport kinetics
was too fast to be measured by the stopped-flow instrument.
Activation of ion transport by high concentrations of agonists
was therefore performed in the presence of 1 MLM HTX to ran-
domly inactivate a fraction of the receptors and thereby slow
the flux rates to measurable levels. By using different recon-
stituted preparations, it was found that inclusion of 1 uM HTX
with 10 or 20 MiM AcCho or 400 MLM CarbCho reduced the flux
rates by a factor of =2. Thus, the apparent rate constants for
Tl flux obtained for agonist concentrations of CarbCho or
AcCho >750 or 30 MLM, respectively, in the presence of 1 AM
HTX were normalized to the expected control values (without
HTX) by applying this factor. Fig. 3 C and D shows the apparent
flux rates determined for different concentrations of CarbCho
and AcCho. The rates for CarbCho began to level off at con-
centrations in the millimolar range. When these data were fit-
ted to a binding isotherm that assumed association of two
CarbCho molecules per activated ion channel (14), a maximal
rate of -490 sec1 was obtained. For activation by AcCho, a
slightly higher value (=670 sect) was estimated. By using the
maximal flux rate obtained for CarbCho, a transport number
of 2 x 106 (ions per reconstituted channel) per second was cal-
culated (see Appendix).
DISCUSSION
Recent reports have described reconstitution ofmembranes de-
rived from crude (28, 29) and purified (15-18) receptor prepa-
rations that translocated cations (22Na+) in response to an ago-
nist. In all cases, transport was measured on the time scale of
seconds and the response was an integrated signal giving only
the amplitude ofthe ion translocation event. We have measured
the kinetics ofion transport across a reconstituted AcChoR-con-
taining membrane by stopped-flow spectroscopy, using a re-
cently developed technique (14) that permits continuous mea-
surement of ion flux.
In a reproducible manner, a rapid acceleration of fluores-
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FIG. 2. Kinetics of CarbCho-induced influx of Tl+ across reconstituted AcChoR membranes. All fluorescence traces shown were obtained by
computer averaging of five or six data sets. (A and B) Reconstituted AcChoR vesicles loaded with ANTS (syringe 1) were rapidly mixed at time
= 0 in a stopped-flow instrument with TINO3/buffer (syringe 2) containing no CarbCho (-) (upper trace) or with 2 mM CarbCho (+) (lower trace);
fluorescence was recorded over period of 100 msec. Fluorescence traces shown were obtained from flux experiments with two different reconstituted
preparations. (C and D) Blockage by HTX. Reconstituted AcChoR vesicles that contained ANTS and had been preincubated with 10 ,M HTX for
5 min at25C (syringe 1) were rapidly mixed with 10,uMHTX in TlNO3/buffer containing no (C) or 2mM (D) CarbCho (syringe 2). (EandF) Blockage
by receptor desensitization. Reconstituted AcChoR vesicles that contained ANTS and had been preincubated with 100 MAM CarbCho for 30 min at
250C (syringe 1) were rapidly mixed with TlNO3/buffer containing no (E) or 2 mM (F) CarbCho (syringe 2). (G andH) Influx into liposomes lacking
AcChoR. Liposomes were prepared in the same manner as reconstituted AcChoR membranes except that AcChoR was not added; they were similarly
loaded with ANTS. Liposomes containing ANTS (syringe 1) were rapidly mixed with TlNO3/buffer containing no (G) or 2 mM (H) CarbCho (syringe
2).
cence decay was obtained by rapidly mixing reconstituted
AcChoR-containing membranes with CarbCho or AcCho; six
different preparations all responded in the manner shown in
Fig. 2 A and B. Specific pharmacological tests on the reconsti-
tuted AcChoR containing vesicles and similar flux experiments
carried out by using liposomes lacking AcChoR suggest that the
observed rapid fluorescence decay indeed represented Ac-
ChoR-mediated transport of Tl+ into the vesicles. The rate of
fluorescence decay accelerated from a half-time of 900 msec in
the absence of CarbCho to 5 msec when 1 mM CarbCho was
added. The apparent rate constant for agonist-independent flu-
orescence decay (leakage) for reconstituted membranes is about
10-fold higher than that for native membranes (decay half-time
of 10 sec; ref. 14). This difference could be accounted for if
the apparent rate constant for Tl+ leakage is proportional to the
ratio of the surface area to the interior volume of the membrane
vesicles; the average diameter of the reconstituted AcChoR
vesicles is approximately an order of magnitude smaller than
that of native membranes.
Two important questions regarding the properties of the
AcChoR are answered by these experiments. The first is
whether the purified AcChoR molecule can be reconstituted
after dissolution in detergent to exhibit the full functional prop-
erties of the physiological receptor in terms of its ability to
transport cations. From the analysis of the ion-flux kinetics (see
Fig. 3), we estimate (see Appendix) that at least 2 X 106 cations
are transported through each reconstituted AcChoR channel
per second. This transport rate compares favorably with that
estimated for purified native membranes (_106 sec-1; ref. 14).
Because the total cation concentrations used in the two prep-
arations were different (four times higher in the reconstituted
system), comparison should be made after normalizing the ca-
tion concentrations. Assuming that the number of ions trans-
ported through each AcChoR channel per second is directly
proportional to the bulk cation concentration, the transport rate
for the reconstituted AcChoR would be lower than, but within
a factor of 2 of, that for native membranes. These numbers are
within an order of magnitude of that determined for an in vivo
AcChoR (=107 sec'; refs. 25-27). The difference may be as-
cribed to receptor inactivation, membrane potential, and the
limited probability for channel opening on agonist binding (30).
The second important implication of the results is that the
AcChoR molecule constitutes the whole assembly necessary for
physiological function: A pentameric complex composed of two
identical subunits of 40,000 daltons and three homologous sub-
units (1) of 50,000, 60, 000, and 65,000 daltons contains both the
elements necessary for agonist or other ligand binding and the
elements necessary for ion transport.
APPENDIX
The number of ions transported per second by each activated
AcChoR in a reconstituted membrane vesicle can be estimated
by dividing the apparent ion transport rate across a single vesicle
by the average number of AcChoR molecules per vesicle.
The apparent ion transport rate across a single vesicle is cal-
culated as follows: The maximal rate constant, obtained at sat-
urating concentrations of CarbCho, is 487 sec1 for Tl+ trans-
port and, under our experimental conditions (Fig. 3), the sum
of the cation concentrations on either side of the vesicle mem-
branes is 0.420 M. The rate of bidirectional cation flux is there-
fore 487 sec&' X 0.42 M = 204.54 M sect. The interior volume
of vesicles having an average diameter of 500 A (or an inner
diameter of 400 A after subtracting membrane thickness) is 3.27
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FIG. 3. Dependence of Tl+ flux rate on agonist concentration. (A and B) Kinetics of Tl influx across reconstituted AcChoR-containing mem-
branes activated by 0, 250, and 1000 A±M CarbCho (A) and by 0, 10, and 20 1.M AcCho (B). (C andD) Apparent flux rates as a function of concentration
of CarbCho (C) or AcCho (D). Kinetic traces obtained from computer averaging of five or six fluorescence traces for each agonist concentration were
computer fitted to equation 1 of ref. 14, which describes the fluorescence decay as a function of time. The Kapp determined was plotted against the
corresponding agonist concentration. Flux experiments using final agonist concentrations >750 AM CarbCho or 30 AM AcCho were performed in
the presence of 1 pM HTX, and the Kapp obtained was normalized to the expected control value (without HTX) by a factor of 2 (empirical factors
averaged from three different reconstituted preparations were 1.81 for CarbCho and 1.90 for AcCho). Plotted rates were fitted to a binding isotherm
that assumed association of two agonist molecules with each activated ion channel; i.e., Kapp = Kr,,/(l + Kd/vol)2. For activation by CarbCho
(C), Kma. 490 sec-1 and Kd 500 ,uM. For AcCho (D), K.. = 670 sec' and Kd = 44 tLM.
x 10-20 liter. Thus, -4 x 106 ions are transported into each
vesicle per second.
The average number of AcChoR oligomers in each vesicle
is estimated as follows: The number of phospholipid molecules
(surface area, 55 A2 per molecule) that constitute a vesicle hav-
ing a diameter 500 A- and a bilayer thickness of 50 A is 2.33
x 104. From the concentrations of a-BuTx binding sites (0.215
,uM) and of phospholipids (3 mM), it is estimated that, on the
average, 1.67 a-BuTx sites are associated with each vesicle. By
taking into account the distribution of a-BuTx binding sites oc-
curring as monomer and dimer (0. 52:0.48, ref. 20) and assuming
that two a-BuTx binding sites are associated with a receptor
monomer in the reconstituted preparation, the number of re-
ceptor oligomers per vesicle is 0.64. As -90% of the reconsti-
tuted AcChoR is oriented with the a-BuTx binding sites on the
outer surface of the vesicles (20), the average number of re-
ceptor oligomers having the correct orientation for agonist bind-
ing is 0.58. If the AcChoR oligomers are distributed among the
vesicles according to a Poisson dsitribution (n = 0.58), the av-
erage number of AcChoR oligomers present in those vesicles
containing at least one oligomer would be 1.32 per vesicle. If
both ion channels associated with an AcChoR dimer are active
in cation transport, there will be 1.96 channels per vesicle.
Dividing the total ion transport rate across each vesicle (4 x 106
ions per sec) by 1.96 AcChoR channels per vesicle, we find the
estimated number of ions transported through each reconsti-
tuted AcChoR at saturating agonist concentrations to be 4 x 106/
1.96 = 2 x 106 (ions/per sec)/AcChoR.
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